Lung Cancer in Singapore
10.1016/j.jtho.2020.11.020
Saved in:
Main Authors: | Ang, Yvonne LE, Chia, Puey Ling, Chua, Kevin LM, Devanand, Anantham, Leong, Cheng Nang, Liew, Charlene JY, Ong, Boon Hean, Samol, Jens, Seet, Ju Ee, Tam, John KC, Tan, Daniel SW, Teo, Lynette LS, Soo, Ross A |
---|---|
Other Authors: | CANCER SCIENCE INSTITUTE OF SINGAPORE |
Format: | Editorial |
Language: | English |
Published: |
ELSEVIER SCIENCE INC
2022
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/234728 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Language: | English |
Similar Items
-
GM2-activator protein: A new biomarker for lung cancer
by: Potprommanee,L., et al.
Published: (2015) -
Characterization of MET-N375S as an Activating Mutation in Squamous Cell Carcinoma of the Lung
by: Kong, Li Ren, et al.
Published: (2024) -
Resisting resistance to cancer immunotherapy
by: RAGHAV SUNDAR, et al.
Published: (2021) -
Real-world experience of consolidation durvalumab after concurrent chemoradiotherapy in stage III non-small cell lung cancer
by: Huang, Yiqing, et al.
Published: (2022) -
NSCLC PATIENTS WITH BOTH WILDTYPE EGFR AND HIGH CD151 EXPRESSION HAVE POORER DISEASE OUTCOME
by: Wong, Amanda, et al.
Published: (2019)